Browsing by Author Ferrero, A.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2012Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trialBrown, Christopher; De Rauglaudre, G; Elit, Laurie; Ferrero, A.; Gladieff, Laurence; Helland, H; Lorusso, D; Mahner, S; Pujade-Lauraine, Eric; Reed, N; Reinthaller, A; Siena, Salvatore; Vasey, P; NH&MRC Clinical Trials CentreCarboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial, Annals of Oncology, vol.23, 5, 2012,pp 1185-1189
2015Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: Analysis of the CALYPSO trialGebski, Val; Lee, Chee Khoon; Lord, Sarah (Sally); Ferrero, A.; Friedlander, Michael; Grunewald, Tami; Hardy-Bessard, Anne Claire; Harter, Philipp; Heywood, M; Pujade-Lauraine, Eric; Scambia, G; Schauer, C; Sehouli, Jalid; Vergote, Ignace; Woie, Kathrine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreImpact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: Analysis of the CALYPSO trial, Gynecologic Oncology, vol.136, 1, 2015,pp 18-24
2011Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancerBrown, Christopher; Gebski, Val; Lee, Chee; Lord, Sarah (Sally); Simes, Robert John; Angleitner-Boubenizek, L.; Bentley, J.; Bourgeois, H.; Burges, A.; Ferrero, A.; Friedlander, Michael; Hirte, H.; Hogberg, T.; Parma, G.; Pfisterer, J.; Pisano, C.; Plante, M.; Pujade-Lauraine, Eric; Richter, B.; Vergote, Ignace; Wagner, U.; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentrePrognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer, British Journal of Cancer, vol.105, 8, 2011,pp 1144-1150